Navigation Links
Cardium Reports On Third Quarter 2013 Financial Results And Recent Business Developments
Date:11/19/2013

in our other reports will be successfully commercialized and their use reimbursed, or will enhance our market value; that new product opportunities or commercialization efforts will be successfully established; that third parties on whom we depend will perform as anticipated; or that the Company will not be adversely affected by risks and uncertainties that could impact our operations, business or other matters, as described in more detail in our filings with the Securities and Exchange Commission. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.

Copyright 2013 Cardium Therapeutics, Inc.  All rights reserved.
For Terms of Use Privacy Policy, please visit www.cardiumthx.com.

Cardium Therapeutics®, Generx®,  Excellagen®, LifeAgain®, BlueMetric™, Decision Rule Adaption™, ADAPT™, Angionetic Therapeutics, Activation Therapeutics™, MedPodium® and Nutra-Apps® are trademarks of Cardium Therapeutics, Inc. or Tissue Repair Company.  Other trademarks belong to their respective owners.

-Continued-

 Cardium Therapeutics, Inc.Selected Condensed Consolidated Results of OperationsThree months ended September 30,Nine months ended September 30,2013201220132012Product sales$
471,566$
5,589$  1,655,342$
39,241Cost of goods sold(288,522)(3,640)(977,912)(15,191)Gross profit183,0441,949677,43024,050Operating expensesResearch and development(315,178)(508,342)(1,566,988)(2,097,675)Selling, general and administrative(1,636,871)(1,389,731)(5,258,129)(4,358,706)Loss from operations(1,769,0
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Unusual Trading Activity In Cardium Common Stock
2. Cardium Reports On Potential Use Of Excellagen To Repair Prenatally Diagnosed Birth Defects Using Mesenchymal Stem Cells
3. Cardium Announces New Excellagen FDA 510(k) Submission Based On Expanded Structural And Functional Properties
4. Cardium Reports On New Excellagen Distribution Agreement With AvKARE For Veterans Hospitals And Other Governmental Medical Facilities
5. Cardium Completes Preferred Stock Financing
6. Cardium Announces Reverse Stock Split
7. Cardium Announces Initial Voting Results And Temporary Adjournment of Annual Meeting To Be Reconvened On June 21, 2013
8. Cardium Presents First Quarter 2013 Financial Results And Reports On Recent Developments
9. Cardium Announces Generx Publication In Molecular Therapy
10. Cardium Announces Excellagen Presentation at the Symposium on Advanced Wound Care Spring 2013 Meeting
11. Cardium Presents Year-End 2012 Financial Results And Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 17, 2014 Prostate Oncology Specialists announces ... to educate men about new imaging technology destined ... prostate. Annually, a million men undergo random needle ... MRI (MP-MRI) of the prostate gland is non-invasive ... need to be fully informed of their alternatives. ...
(Date:9/17/2014)...  Rebiotix Inc. announced this morning that results of the ... (microbiota suspension) will be presented in two posters and a ... Philadelphia from October 8-12. PUNCH ... on Thursday, October 9, 2014: Poster: RBX2660 (microbiota ... Analysis of the PUNCH-CD Phase 2 Safety Study ...
(Date:9/17/2014)... and SAN JOSE, Calif. , ... has been named as a laureate of The Tech Awards ... applying technology to benefit humanity and spark global change. The ... Innovation, and presented by Applied Materials, Inc., selected Gradian as ... Photo - http://photos.prnewswire.com/prnh/20140917/146680 ...
Breaking Medicine Technology:Prostate Cancer Awareness Month - Stop Random Biopsies 2Prostate Cancer Awareness Month - Stop Random Biopsies 3PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 2PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 3PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 4Gradian Health Systems Named A 2014 Laureate of The Tech Awards 2Gradian Health Systems Named A 2014 Laureate of The Tech Awards 3
(Date:9/17/2014)... (PRWEB) September 17, 2014 Final Cut Pro ... entitled ProBlue 5k from Pixel Film Studios. , “ProBlue 5k ... users video from good to epic,” said Christina Austin, CEO ... armature, ProBlue 5k is a definite game changer.” , ProBlue ... package for any filmmaker ! This footage compilation of ...
(Date:9/17/2014)... 2014 People who struggle to distinguish between ... http://www.perwickstrom.com and get the answer by reading Per ... out, is that a business plan and a business strategy ... commented Per Wickstrom. “The way I view it is that ... strategy which is part two.” , According to the ...
(Date:9/17/2014)... IL (PRWEB) September 17, 2014 The ... Pseudomonas aeruginosa infections allegedly caused by Non-Sterile Other-Sonic ... learn more about their options for legal recourse. Other-Sonic ... Drug Administration (FDA) in March 2012, after the product ... aeruginosa at William Beaumont Hospital in Royal Oak, Michigan ...
(Date:9/17/2014)... Dennis Thompson HealthDay Reporter ... in the womb to household chemicals known as phthalates ... Columbia University researchers reported in a new study. ... developing asthma between age 5 and 11 if their ... two phthalates (pronounced thal-ates), the researchers found. The two ...
(Date:9/17/2014)... FRISCO, Texas (PRWEB) September 17, 2014 ... (EV-D68) outbreak that is hospitalizing scores of infants, children ... Louisiana, says Dr. Kirk Mahon, medical director of Legacy ... , “There have been no reported cases of EV-D68 ... Oklahoma and Louisiana, that could change,” he said. “Implementing ...
Breaking Medicine News(10 mins):Health News:A New Plugin Entitled ProBlue 5k Was Released Today from Pixel Film Studios Exclusively for Final Cut Pro X 2Health News:Per Wickstrom’s Latest Blog Explores the Difference Between a Business Plan and a Business Strategy 2Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 2Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 3Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 4Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 2Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 3Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 4Health News:Legacy ER & Urgent Care Warns North Texans about Dangers of Enterovirus D68 2
... 17 (HealthDay News) -- Among long-term breast cancer survivors, those ... much higher rates of death due to heart disease, new ... Jan. 25 issue of the Journal of the American ... such as that practiced until the mid-1980s, increased the long-term ...
... birth weight in First Nations (North American Indian) babies are ... that occur from 4 weeks to 1 year of age), ... Canadian Medical Association Journal ) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100837.pdf ... as a child being born above the 90th percentile relative ...
... By Steven Reinberg HealthDay Reporter , ... are taking common blood pressure medications called calcium channel ... blood pressure and possibly going into shock if they ... antibiotics, erythromycin and clarithromycin, if given to patients taking ...
... on the milk we drink, according to new research ... during a particularly poor UK summer and the following ... less beneficial fatty acids than in a more ,normal, ... organic milk could help overcome these problems. Organic ...
... HealthDay Reporter , SATURDAY, Jan. 15 (HealthDay News) -- ... the breathing tube that had been in place since she ... attack in Tucson that killed six people. The new ... the Associated Press . The breathing tube had been ...
... January 14, 2011The ongoing controversy about the appropriate ... be explored at the upcoming 19th Annual Congress ... DC. A provocative "Point-Counterpoint: The Mammography Controversy" will ... PhD, Visiting Professor of Radiology, Magee-Womens Hospital, University ...
Cached Medicine News:Health News:Breast Cancer Radiation Before 1984 Tied to Heart Disease 2Health News:High birth weight in First Nations babies linked to a higher risk of postneonatal death 2Health News:Some Antibiotics, Blood Pressure Meds a Bad Mix: Study 2Health News:Some Antibiotics, Blood Pressure Meds a Bad Mix: Study 3Health News:Choosing organic milk could offset effects of climate change 2Health News:Choosing organic milk could offset effects of climate change 3Health News:Choosing organic milk could offset effects of climate change 4Health News:Rep. Giffords Has Surgery to Replace Breathing Tube 2Health News:Rep. Giffords Has Surgery to Replace Breathing Tube 3Health News:Mammography controversy to be explored at 19th Annual Congress on Women's Health 2
For the quantitative in vitro determination of Microalbumin in urine....
Determination of the Thrombin Time by STA Analyzers. Freeze-dried human thrombin (1.5NIH units/mL) with calcium....
Determination of Activated Partial Thromboplastin Time (APTT) by STA Analyzers. Cephalin reagent with kaolin activator....
Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
Medicine Products: